FDA National Officer Allan Sampson has raised concerns over Prime Minister Boris Johnson’s announcement that the Department for International Development (DFID) and the Foreign and Commonwealth Office (FCO) are to merge, warning that the news “has created huge uncertainty and unease for DFID staff”.
While speculation about the merger has existed for several months, Sampson criticised the fact many staff found out about the merger through media reports instead of from their employer.
Sampson has defended DFID as a department “with a strong reputation for success” whose staff are “working tirelessly to lead the UK’s global efforts to respond to COVID-19 and protect the poorest and most vulnerable people around the world”.
He explained: “A recent International Development Committee report commended DFID’s standing as a global development agency and the excellence of the department’s programming and transparency, and urged against a disruptive and costly machinery of government reorganisation that would impact the effectiveness of aid.
“DFID has also operated successfully over two sites and employs a significant number of staff outside of London. Those staff, and many others, will now understandably be concerned for their future and disappointed to hear about this through leaks to the media.”
While these changes begin to address challenges identified by our members in the CPS, the union continues its call for increased CPS funding, in order to help tackle these crimes long-term.
The FDA sign formal recognition agreement for special advisers with Satvir Kaur MP, Parliamentary Secretary for the Cabinet Office
In response to announcements on civil service pay, the FDA welcome progression for Senior Civil Servants, but introducing progression for other grades remains ‘top pay priority’ after ‘lack of meaningful change for two decades’.
